| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |